Epitope characterization of ovalbumin in BALB/c mice using different entry routes

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1774, Issue 2, 2007, Pages 200-212

  Mine, Yoshinori ^a   Yang, Marie ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

BALB c mouse; Immunoglobulin E epitope mapping; Ovalbumin; Route of immunization; SPOTS membrane

Indexed keywords

EPITOPE; IMMUNOGLOBULIN E; OVALBUMIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; FEMALE; IMMUNIZATION; IMMUNOCHEMISTRY; IMMUNOTHERAPY; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; EPITOPES; FEMALE; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; OVALBUMIN; PROTEIN CONFORMATION;

MURINAE; MUS;

EID: 33846828273     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2006.12.003     Document Type: Article

References (73)

1. Bischoff S., and Crowe S.E. Gastrointestinal food allergy: new insights into pathophysiology and clinical perspectives. Gastroenterology 128 4 (2005) 1089-1113
2. Sicherer S.H. Food allergy. Lancet 360 9334 (2002) 701-710
3. Breiteneder H., and Mills E.N. Molecular properties of food allergens. J. Allergy Clin. Immunol. 115 1 (2005) 14-23
4. Sampson H.A. Update on food allergy. J. Allergy Clin. Immunol. 113 5 (2004) 805-819
5. Sicherer S.H., and Sampson H.A. Food allergy. J. Allergy Clin. Immunol. 117 Supp. 2 (2006) S470-S475
6. Milling S.W., Cousins L., and MacPherson G.G. How do DCs interact with intestinal antigens?. Trends Immunol. 26 7 (2005) 349-352
7. Zimmer K.P., Buning J., Weber P., Kaiserlian D., and Strobel S. Modulation of antigen trafficking to MHC class II-positive late endosomes of enterocytes. Gastroenterology 118 1 (2000) 128-137
8. Beyer K., and Teuber S.S. Food allergy diagnostics: scientific and unproven procedures. Curr. Opin. Allergy Clin. Immunol. 5 3 (2005) 261-266
9. Akdis C.A., and Blaser K. Regulation of specific immune responses by chemical and structural modifications of allergens. Int. Arch. Allergy Immunol. 121 4 (2000) 261-269
10. Shimojo N., Katsuki T., Coligan J.E., Nishimura Y., Sasazuki T., Tsunoo H., Sakamaki T., Kohno Y., and Niimi H. Identification of the disease-related T cell epitope of ovalbumin and epitope-targeted T cell inactivation in egg allergy. Int. Arch. Allergy Immunol. 105 2 (1994) 155-161
11. Mine Y., and Rupa P. Immunological and biochemical properties of egg allergens. Poult. Sci. 60 (2004) 321-330
12. Waldemer T. Egg proteins. In: Zdzislaw E.S. (Ed). Chemical and Functional Properties of Food Proteins (2001), CRC Press Lancaster, Pennsylvania, PA 335-371
13. Elsayed S., Holen E., and Haugstad M.B. Antigenic and allergenic determinants of ovalbumin. II. The reactivity of the NH2 terminal decapeptide. Scand. J. Immunol. 27 5 (1988) 587-591
14. Elsayed S., and Stavseng L. Epitope mapping of region 11-70 of ovalbumin (Gal d I) using five synthetic peptides. Int. Arch. Allergy Immunol. 104 1 (1994) 65-71
15. Kahlert H., Petersen A., Becker W.M., and Schlaak M. Epitope analysis of the allergen ovalbumin (Gal d II) with monoclonal antibodies and patients' IgE. Mol. Immunol. 29 10 (1992) 1191-1201
16. Masuda T., Koseki S.Y., Yasumoto K., and Kitabatake N. Characterization of anti-irradiation-denatured ovalbumin monoclonal antibodies. Immunochemical and structural analysis of irradiation-denatured ovalbumin. J. Agric. Food Chem. 48 7 (2000) 2670-2674
17. Honma K., Kohno Y., Saito K., Shimojo N., Horiuchi T., Hayashi H., Suzuki N., Hosoya T., Tsunoo H., and Niimi H. Allergenic epitopes of ovalbumin (OVA) in patients with hen's egg allergy: inhibition of basophil histamine release by haptenic ovalbumin peptide. Clin. Exp. Immunol. 103 3 (1996) 446-453
18. Sette A., Buus S., Colon S., Smith J.A., Miles C., and Grey H.M. Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells. Nature 328 6129 (1987) 395-399
19. Buus S., Sette A., and Grey H.M. The interaction between protein-derived immunogenic peptides and Ia. Immunol. Rev. 98 (1987) 115-141
20. Renz H., Bradley K., Larsen G.L., McCall C., and Gelfand E.W. Comparison of the allergenicity of ovalbumin and ovalbumin peptide 323-339. Differential expansion of V beta-expressing T cell populations. J. Immunol. 151 12 (1993) 7206-7213
21. Janssen E.M., Wauben M.H., Jonker E.H., Hofman G., Van Eden W., Nijkamp F.P., and Van Oosterhout A.J. Opposite effects of immunotherapy with ovalbumin and the immunodominant T-cell epitope on airway eosinophilia and hyperresponsiveness in a murine model of allergic asthma. Am. J. Respir. Cell Mol. Biol. 21 1 (1999) 21-29
22. Sun J., Dirden-Kramer B., Ito K., Ernst P.B., and Van Houten N. Antigen-specific T cell activation and proliferation during oral tolerance induction. J. Immunol. 162 10 (1999) 5868-5875
23. Janssen E.M., van Oosterhout A.J., van Rensen A.J., van Eden W., Nijkamp F.P., and Wauben M.H. Modulation of Th2 responses by peptide analogues in a murine model of allergic asthma: amelioration or deterioration of the disease process depends on the Th1 or Th2 skewing characteristics of the therapeutic peptide. J. Immunol. 164 2 (2000) 580-588
24. Ohta A., Sato N., Yahata T., Ohmi Y., Santa K., Sato T., Tashiro H., Habu S., and Nishimura T. Manipulation of Th1/Th2 balance in vivo by adoptive transfer of antigen-specific Th1 or Th2 cells. J. Immunol. Methods 209 1 (1997) 85-92
25. Sato T., Sasahara T., Nakamura Y., Osaki T., Hasegawa T., Tadakuma T., Arata Y., Katsuki K.Y.M., and Habu S. Naive T cells can mediate delayed-type hypersensitivity response in T cell receptor transgenic mice. Eur. J. Immunol. 24 7 (1994) 1512-1516
26. Mine Y., and Rupa P. Fine mapping and structural analysis of immunodominant IgE allergenic epitopes in chicken egg ovalbumin. Protein Eng. 16 10 (2003) 747-752
27. Kimber I., Dearman R.J., Penninks A.H., Knippels L.M., Buchanan R.B., Hammerberg B., Jackson H.A., and Helm R.M. Assessment of protein allergenicity on the basis of immune reactivity: animal models. Environ. Health Perspect. 111 8 (2003) 1125-1130
28. Strid J., Thomson M., Hourihane J., Kimber I., and Strobel S. A novel model of sensitization and oral tolerance to peanut protein. Immunology 113 3 (2004) 293-303
29. Kimber I., and Dearman R.J. Factors affecting the development of food allergy. Proc. Nutr. Soc. 61 4 (2002) 435-439
30. Nelde A., Teufel M., Hahn C., Duschl A., Sebald W., Brocker E.B., and Grunewald S.M. The impact of the route and frequency of antigen exposure on the IgE response in allergy. Int. Arch. Allergy Immunol. 124 4 (2001) 461-469
31. Knippels L.M., Penninks A.H., van Meeteren M., and Houben G.F. Humoral and cellular immune responses in different rat strains on oral exposure to ovalbumin. Food Chem. Toxicol. 37 8 (1999) 881-888
32. Cox J.C., and Coulter A.R. Adjuvants-A classification and review of their modes of action. Vaccine 15 3 (1997) 248-256
33. Dearman R.J., Caddick H., Stone S., Basketter D.A., and Kimber I. Characterization of antibody responses induced in rodents by exposure to food proteins: influence of route of exposure. Toxicology 167 3 (2001) 217-231
34. Bowen J.C., Reddy R.M., and Rouse B.T. Cholera toxin-mediated cellular immune responses against ovalbumin administered orally. Adv. Exp. Med. Biol. 371B (1995) 1531-1533
35. Repa A., Wild C., Hufnagl K., Winkler B., Bohle B., Pollak A., and Wiedermann U. Influence of the route of sensitization on local and systemic immune responses in a murine model of type I allergy. Clin. Exp. Immunol. 137 1 (2004) 12-18
36. Faquim-Mauro E.L., and Macedo M.S. Induction of IL-4-dependent, anaphylactic-type and IL-4-independent, non-anaphylactic-type IgG1 antibodies is modulated by adjuvants. Int. Immunol. 12 12 (2000) 1733-1740
37. Todryk S.M., Kelly C.G., and Lehner T. Effect of route of immunisation and adjuvant on T and B cell epitope recognition within a streptococcal antigen. Vaccine 16 2-3 (1998) 174-180
38. Elson C.O., and Eadling W. Generalized systemic and mucosal immunity in mice after mucosal stimulation with Cholera toxin. J. Immunol. 132 (1984) 2736-2741
39. Lycke N., and Holmgren J. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 59 (1986) 301-308
40. Kroghsbo S., Christensen H.R., and Frokiaer H. Experimental parameters differentially affect the humoral response of the cholera toxin- based murine model of food allergy. Int. Arch. Allergy Immunol. 131 4 (2003) 256-263
41. Li X.-M., Schofield B.H., Huang C.-K., Kleiner G.I., and Sampson H.A. A murine model of IgE-mediated cows milk hypersensitivity. J. Allergy Clin. Immunol. 103 (1999) 206-214
42. Huang C.K., Bardina L., Schofield B.H., Stanley J.S., Burks A.W., Bannon G.A., and Sampson H.A. A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses. J. Allergy Clin. Immunol. 106 (2000) 150-158
43. Gizarelli F., Corinti S., Barletta B., Iacovacci P., Brunetto B., Butteroni C., Afferni C., Onori R., Miraglia M., Panzini G., Di Felice G., and Tinghino R. Evaluation of allergenicity of genetically modified soybean protein extract in a murine model of oral allergen-specific sensitization. Clin. Exp. Allergy 36 2 (2006) 238-248
44. Marinaro M., Staats H.F., Hiroi T., Jackson R.J., Coste M., Boyaka P.N., Okahashi N., Yamamoto M., Kiyono H., Bluethmann H., Fujihashi K., and McGhee J.R. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J. Immunol. 155 10 (1995) 4621-4629
45. Wilson A.D., Stokes C.R., and Bourne F.J. Adjuvant effect of cholera toxin on the mucosal immune response to soluble proteins. Differences between mouse strains and protein antigens. Scand. J. Immunol. 29 6 (1989) 739-745
46. Rupa P., and Mine Y. Immunological comparison of native and recombinant egg allergen, ovalbumin, expressed in Escherichia coli. Biotechnol. Lett. 25 22 (2003) 1917-1924
47. Externest D., Meckelein B., Schmidt M.A., and Frey A. Correlations between antibody immune responses at different mucosal effector sites are controlled by antigen type and dosage. Infect. Immun. 68 7 (2000) 3830-3839
48. Hopp T.P., and Woods K.R. A computer program for predicting protein antigenic determinants. Mol. Immunol. 20 4 (1983) 483-489
49. Francis J.N., and Larche M. Peptide-based vaccination: where do we stand?. Curr. Opin. Allergy Clin. Immunol. 5 6 (2005) 537-543
50. Rupa P., and Mine Y. Engineered recombinant ovomucoid third domain can modulate allergenic response in Balb/c mice model. Biochem. Biophys. Res. Commun. 342 3 (2006) 710-717
51. Ivanciuc O., Schein C.H., and Braun W. SDAP: database and computational tools for allergenic proteins. Nucleic Acids Res. 31 1 (2003) 359-362
52. Saldanha J.C., Gargiulo D.L., Silva S.S., Carmo-Pinto F.H., Andrade M.C., Alvarez-Leite J.I., Teixeira M.M., and Cara D.C. A model of chronic IgE-mediated food allergy in ovalbumin-sensitized mice. Braz. J. Med. Biol. Res. 37 6 (2004) 809-816
53. Adel-Patient K., Bernard H., Ah-Leung S., Creminon C., and Wal J.M. Peanut- and cow's milk-specific IgE, Th2 cells and local anaphylactic reaction are induced in Balb/c mice orally sensitized with cholera toxin. Allergy 60 5 (2004) 658-664
54. Haley P.J. Species differences in the structure and function of the immune system. Toxicology 188 1 (2003) 49-71
55. McClain S., and Bannon G.A. Animal models of food allergy: opportunities and barriers. Curr. Allergy Asthma Rep. 6 (2006) 141-144
56. Burks AW S.D., Cockrell G., Stanley J.S., Helm R.M., and Bannon G.A. Mapping and mutational analysis of the IgE-binding epitopes on Ara h 1, a legume vicilin protein and a major allergen in peanut hypersensitivity. Eur. J. Biochem. 245 2 (1997) 334-339
57. Rabjohn P., Helm E.M., Stanley J.S., West C.M., Sampson H.A., Burks A.W., and Bannon G.A. Molecular cloning and epitope analysis of the peanut allergen Ara h 3. J. Clin. Invest. 103 4 (1999) 535-542
58. Shreedhar V.K., Kelsall B.L., and Neutra M.R. Cholera toxin induces migration of dendritic cells from the subepithelial dome region to T- and B-cell areas of Peyer's patches. Infect. Immun. 71 1 (2003) 504-509
59. Alving C.R. Design and selection of vaccine adjuvants: animal models and human trials. Vaccine 20 Suppl. 3 (2002) S56-S64
60. Schijns V.E. Immunological concepts of vaccine adjuvant activity. Curr. Opin. Immunol. 12 4 (2000) 456-463
61. Xu-Amano J., Kiyono H., Jackson R.J., Staats H.F., Fujihashi K., Burrows P.D., Elson C.O., Pillai S., and McGhee J.R. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J. Exp. Med. 178 4 (1993) 1309-1320
62. Fernandez I.M., Harmsen M., Benaissa-Trouw B.J., Stuij I., Puyk W., Meloen R.H., Snippe H., and Kraaijeveld C.A. Epitope polarity and adjuvants influence the fine specificity of the humoral response against Semliki Forest virus specific peptide vaccines. Vaccine 16 16 (1998) 1531-1536
63. Verheul A.F., Poolman J.T., Snippe H., and Verhoef J. The influence of the adjuvant Quil A on the epitope specificity of meningococcal lipopolysaccharide anti-carbohydrate antibodies. Mol. Immunol. 28 11 (1991) 1193-1200
64. Lindblad E.B. Mineral adjuvants. In: Schijns E.J.C., and O'Hagan D.T. (Eds). Immunopotentiators in Modern Vaccines (2006), Elsevier Academic Press, San Diego CA 217-233
65. Lavelle E.C., Leavy O., and Mills K.H.G. Modified bacterial adjuvants. In: Hacket C.J., and Harn D.A. (Eds). Vaccine Adjuvants-Immunological and Clinical Principles (2006), Humana Press, Totowa NJ 111-154
66. Bahr G.M. Immune and antiviral effects of the synthetic immunomodulator murabutide. In: Hacket C.J., and Harn D.A. (Eds). Vaccine Adjuvants- Immunological and Clinical Principles (2006), Humana Press, Totowa, NJ 193-219
67. Kensil C.R., Liu G., Anderson C., and Storey J. Effects of QS-21 on innate and adaptive immune responses. In: Hacket C.J., and Harn D.A. (Eds). Vaccine Adjuvants-Immunological and Clinical Principles (2006), Humana Press, Totowa, NJ 221-234
68. Kapsenberg M.L., Hilkens C.M., Wierenga E.A., and Kalinski P. The role of antigen-presenting cells in the regulation of allergen-specific T cell responses. Curr. Opin. Immunol. 10 6 (1998) 607-613
69. Yang M., Wang Y.Y., Zhang L., Chong P., and Mohapatra S.S. Host genetic and adjuvant factors influence epitope specificity to a major recombinant grass allergen. Int. Arch. Allergy Immunol. 111 2 (1996) 173-181
70. Vidard L., Rock K.L., and Benacerraf B. Heterogeneity in antigen processing by different types of antigen-presenting cells. Effect of cell culture on antigen processing ability. J. Immunol. 149 6 (1992) 1905-1911
71. Fu T.J. Digestion stability as a criterion for protein allergenicity assessment. Ann. N. Y. Acad. Sci. 964 (2002) 99-110
72. Poulsen L.K. In search of a new paradigm: mechanisms of sensitization and elicitation of food allergy. Allergy 60 5 (2005) 549-558
73. Vassilopoulou E., Rigby N., Moreno F.J., Zuidmeer L., Akkerdaas J., Tassios I., Papadopoulos N.G., Saxoni-Papageorgiou P., van Ree R., and Mills C. Effect of in vitro gastric and duodenal digestion on the allergenicity of grape lipid transfer protein. J. Allergy Clin. Immunol. 118 2 (2006) 473-480